These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34261587)

  • 1. Conceptualising hepatitis C stigma: A thematic synthesis of qualitative research.
    Harris M; Guy D; Picchio CA; White TM; Rhodes T; Lazarus JV
    Int J Drug Policy; 2021 Oct; 96():103320. PubMed ID: 34261587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A qualitative study of perceived barriers to hepatitis C care among people who did not attend appointments in the non-urban US South.
    Sherbuk JE; Tabackman A; McManus KA; Kemp Knick T; Schexnayder J; Flickinger TE; Dillingham R
    Harm Reduct J; 2020 Sep; 17(1):64. PubMed ID: 32948189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Views and experiences of hepatitis C testing and diagnosis among people who inject drugs: systematic review of qualitative research.
    Jones L; Atkinson A; Bates G; McCoy E; Porcellato L; Beynon C; McVeigh J; Bellis MA
    Int J Drug Policy; 2014 Mar; 25(2):204-11. PubMed ID: 24332457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrimination by health care workers versus discrimination by others: countervailing forces on HCV treatment intentions.
    Brener L; Horwitz R; von Hippel C; Bryant J; Treloar C
    Psychol Health Med; 2015; 20(2):148-53. PubMed ID: 24889417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient and healthcare provider experiences of hepatitis C treatment with direct-acting antivirals in Rwanda: a qualitative exploration of barriers and facilitators.
    Serumondo J; Penkunas MJ; Niyikora J; Ngwije A; Kiromera A; Musabeyezu E; Umutesi J; Umuraza S; Musengimana G; Nsanzimana S
    BMC Public Health; 2020 Jun; 20(1):946. PubMed ID: 32546216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Everybody living with a chronic disease is entitled to be cured": Challenges and opportunities in scaling up access to direct-acting antiviral hepatitis C virus treatment among people who inject drugs.
    Goodyear T; Ti L; Carrieri P; Small W; Knight R
    Int J Drug Policy; 2020 Jul; 81():102766. PubMed ID: 32416525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding access to healthcare for people who use drugs and sex workers: hepatitis C elimination implications from a qualitative study of healthcare experiences in British Columbia, Canada.
    Cunningham NE; Lamb J; Staller A; Krajden M; Hogg RS; Towle A; Lima VD; Salters K
    Harm Reduct J; 2024 Apr; 21(1):75. PubMed ID: 38575970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evolutionary concept analysis: stigma among women living with hepatitis C.
    Masterman C; Mendlowitz AB; Capraru C; Campbell K; Eastabrook G; Yudin MH; Kushner T; Flemming JA; Feld JJ; Babenko-Mould Y; Tryphonopoulos P; Biondi M
    BMC Public Health; 2024 Sep; 24(1):2660. PubMed ID: 39342214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Living with Hepatitis C Virus: A Systematic Review and Narrative Synthesis of Qualitative Literature.
    Dowsett LE; Coward S; Lorenzetti DL; MacKean G; Clement F
    Can J Gastroenterol Hepatol; 2017; 2017():3268650. PubMed ID: 28529936
    [No Abstract]   [Full Text] [Related]  

  • 11. Stigma, HIV and health: a qualitative synthesis.
    Chambers LA; Rueda S; Baker DN; Wilson MG; Deutsch R; Raeifar E; Rourke SB;
    BMC Public Health; 2015 Sep; 15():848. PubMed ID: 26334626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enablers and barriers for the provision of community-based HCV treatment: A case study of a real-world practice.
    Pourmarzi D; Smirnov A; Hall L; Thompson H; FitzGerald G; Rahman T
    J Viral Hepat; 2020 May; 27(5):484-496. PubMed ID: 31958355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. At the intersection of marginalised identities: lesbian, gay, bisexual and transgender people's experiences of injecting drug use and hepatitis C seroconversion.
    Deacon RM; Mooney-Somers J; Treloar C; Maher L
    Health Soc Care Community; 2013 Jul; 21(4):402-10. PubMed ID: 23465052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Shaping the new freedom": A reflexive thematic analysis on patients' post cure needs after years of living with hepatitis C.
    Guggisberg H; Nicca D; Kohler A; Bruggmann P; Patrizia Künzler-Heule P
    Swiss Med Wkly; 2022 Jun; 152():w30177. PubMed ID: 35704926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Sobriety equals getting rid of hepatitis C": A qualitative study exploring the interplay of substance use disorder and hepatitis C among hospitalized adults.
    Vega TA; Levander XA; Seaman A; Korthuis PT; Englander H
    J Subst Abuse Treat; 2021 Aug; 127():108337. PubMed ID: 34134860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving access to care for people who inject drugs: Qualitative evaluation of project ITTREAT-An integrated community hepatitis C service.
    Phillips C; Schulkind J; O'Sullivan M; Edelman N; Smith HE; Verma S; Jones CJ
    J Viral Hepat; 2020 Feb; 27(2):176-187. PubMed ID: 31566851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-Related Quality of Life for individuals with hepatitis C: A narrative review.
    Whiteley D; Elliott L; Cunningham-Burley S; Whittaker A
    Int J Drug Policy; 2015 Oct; 26(10):936-49. PubMed ID: 26050082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The social production of hepatitis C risk among injecting drug users: a qualitative synthesis.
    Rhodes T; Treloar C
    Addiction; 2008 Oct; 103(10):1593-603. PubMed ID: 18821870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The common sense model applied to hepatitis C: a qualitative analysis of the impact of disease comparison and witnessed death on hepatitis C illness perception.
    Safo SA; Batchelder A; Peyser D; Litwin AH
    Harm Reduct J; 2015 Jun; 12():20. PubMed ID: 26092261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding barriers to hepatitis C virus care and stigmatization from a social perspective.
    Treloar C; Rance J; Backmund M
    Clin Infect Dis; 2013 Aug; 57 Suppl 2():S51-5. PubMed ID: 23884066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.